Loss of T cell receptor Vβ repertoires in HIV type 1-infected SCID-hu mice

AIDS Research and Human Retroviruses

Volumn 13, Issue 2, 1997, Pages 125-134

  Boldt Houle, Deborah M ^a,b   Jamieson, Beth D ^c   Aldrovandi, Grace M ^c   Rinaldo Jr , Charles R ^a   Ehrlich, Garth D ^a   Zack, Jerome A ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; COMBINED IMMUNODEFICIENCY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MOUSE; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; VIRUS CELL INTERACTION;

EID: 0031030446     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.125     Document Type: Article

References (60)

1. Dalgleish AG, Wilson S, Gompels M, Lludlam D, Gazzard B, Coates AM, and Habeshaw J: T-cell receptor variable gene products and early HIV-1 infection. Lancet 1992;339:824-828.
2. Imberti L, Sottini A, Bettinardi A, Puoti M, and Primi D: Selective depletion in HIV infection of T-cells that bear specific T cell receptor Vβ sequences. Science 1991;254:860-862.
3. Rebai N, Pantaleo G, DeMarest JF, Ciurli C, Soudeyns H, Adehberger JW, Vaccaressa M, Walker RE, Sekaly RP, and Fauci AS: Analysis of the T-cell receptor β-chain variable-region (Vβ) repertoire in monozygotic twins discordant for human immunodeficiency virus: Evidence for perturbations of specific Vβ segments in CD4+ T cells of the virus-positive twins. Proc Natl Acad Sci USA 1994;91:1529-1533.
4. Soudeyns H, Rebai N, Pantaleo GP, Ciurli C, Boghossian T, Sekaly R, and Fauci AS: The T cell receptor Vβ repertoire in HIV-1 infection and disease. Semin Immunol 1993;5:175-185.
5. Bisset LR: Looking for a "superantigen" in AIDS: A possible role for Mycoplasma? Med Hypoth 1993;40:146-153.
6. Brinchmann JE, Gaudernack G, Thorsby E, and Vartdal F: Staphylococcal exotoxin superantigens induce human immunodeficiency virus type 1 expression in naturally infected CD4+ T cells. J Virol 1992;66:5964-5928.
7. Kappler JW, Roehm W, and Marrack P: T cell tolerance by clonal elimination in the thymus. Cell 1987;49:273-280.
8. Kappler JW, Staerz U, White J, and Marrack PC: Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature (London) 1988;332:35-40.
9. Kappler JW, Wade T, White J, Kushner E, Blackman M, Bill J, Roehm N, and Marrack P: A T cell receptor Vβ segment that imparts reactivity to a class II major histocompatibility complex product. Cell 1987;49:263-271.
10. a expressing cells. Nature (London) 1989;339: 541-544.
11. Dyson PJ, Knight AM, Fairchild S, Simpson E, and Tomonari K: Genes encoding ligands for deletion of Vβ11 T cells cosegregate with mammary tumour virus genomes. Nature (London) 1991; 349:531-532.
12. Frankel WN, Rudy C, Coffin JM, and Huber BT: Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice. Nature (London) 1991;349:526-528.
13. Marrack P, Kushnir E, and Kappler J: A maternally inherited superantigen encoded by a mammary tumour virus. Nature (London) 1991;349:524-526.
14. Woodland D, Happ MP, Bill J, and Palmer E: Requirement for cotolerogenic gene products in clonal deletion of I-E reactive T cells. Science 1990;247:964-967.
15. Woodland DL, Happ MP, Gollob KJ, and Palmer E: An endogenous retrovirus mediating deletion of α/β T cells? Nature (London) 1991;349:529-530.
16. Cole BC, and Atkin CL: The Mycoplasma arthritidis T-cell mitogen, MAM: A model superantigen. Immunol Today 1991;12: 271-276.
17. Lafon M, Lafage M, Martinez-Arends A, Ramirez R, Vuiller F, Charron D, Lotteau V, and Scott-Algara D: Evidence for a viral superantigen in humans. Nature (London) 1992;358:507-510.
18. White J, Herman A, Pullen AM, Kubo R, Kappler JW, and Marrack P: The Vβ-specific superantigen staphyloccocal enterotoxin B: Stimulation of mature T-cells and clonal deletion in neonatal mice. Cell 1989;56:27-35.
19. Dadaglio G, Garcia S, Montagnier L, and Gougeon ML: Selective anergy of V beta 8+ T cells in human immunodeficiency virus-infected individuals. J Exp Med 1994;179:413-424.
20. Boldt-Houle DM, Rinaldo CR Jr, and Ehrlich GD: Random depletion of T cells that bear specific T-cell receptor Vβ sequences in AIDS patients. J Leuk Biol 1993;54:486-491.
21. Boyer V, Smith LR, Ferre F, Pezzoli P, Trauger RJ, Jensen FC, and Carlo DJ: T cell receptor V beta repertoire in HIV-infected individuals: Lack of evidence for selective V beta deletion. Clin Exp Immunol 1993;92:437-441.
22. Posnett DN, Kabak S, Hodtsev AS, Goldberg EA, and Asch A: T-cell antigen receptor V beta subsets are not preferentially deleted in AIDS. AIDS 1993;7:625-631.
23. Bisset LR and Fierz W: Areas of sequence homology between several staphylococcal exotoxin "superantigens" and the HIV-1 Pol protein. AIDS Res Hum Retroviruses 1992;8:1543-1544.
24. Goodenow M, Huet T, Saurin W, Kwok S, Sninsky J, and Wain-Hobson S: HIV-1 isolates are rapidly evolving quasispecies: Evidence for viral mixtures and preferred nucleotide substitutions. J AIDS 1989;2:344-352.
25. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, and Haase AT: Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 1993;362:359-362.
26. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, and Fauci AS: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature (London) 1993;362:355-358.
27. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, and Weissman IL: The SCID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 1988;241:1632-1639.
28. Namikawa R, Weilbaecter K, Kareshima H, Yee E, and McCune JM: Long term human hepatopoeisis in the SCID-hu mouse. J Exp Med 1990;172:1055-1063.
29. Grunewald J, Skankar NR, Wigzell H, and Janson CH: An analysis of α/β TCR V gene expression in the human thymus. Int Immunol 1991;7:699-702.
30. Vandekerokhove BAE, Baccala R, Jones D, Kono DH, Theofilopoulos AN, and Roncarolo M: Thymic selection of the human T cell receptor Vβ repertoire in SCID-hu mice. J Exp Med 1992;176:1619-1624.
31. Waller EK, San-Majumdar A, Kamel OW, Hansteen GA, Schick MR, and Weissman IL: Human T-cell development in SCID-hu mice: Staphylococcal enterotoxins induce specific clonal deletions, proliferation, and anergy. Blood 1992;60:3144-3150.
32. Aldrovandi GM, Feuer G, Gao L, Jamieson B, Kristeva M, Chen ISY, and Zack JA: The SCID-hu mouse as a model for HIV-1 infection. Nature (London) 1993;363:732-736.
33. Bonyhadi ML, Rabin L, Salimi S, Brown DA, Kosek J, McCune JM, and Kaneshima H: HIV induces thymus depletion in vivo. Nature (London) 1993;363:728-736.
34. Jamieson BD, Aldrovandi GM, Planelles V, Jowett JBM, Gao L, Bloch LM, Chen ISY, and Zack JA: Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J Virol 1994;61:3478-3485.
35. Stanley SK, McCune JM, Kaneshima H, Justement JS, Sullivan M, Boone E, Baseler M, Adelsberger M, Bonyhadi M, Orenstein J, Fox CH, and Fauci AS: Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med 1993;178:1151-1163.
36. Bosma GC, Custer RP, and Bosma MJ: A severe combined immunodeficiency mutation in the mouse. Nature (London) 1983;301:527-530.
37. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, and Martin MA: Production of acquired immunodeficiency syndrome-associated retrovirus in human and non-human cells transfected with an infectious molecular clone. J Virol 1986; 59:284-291.
38. Cann AJ, Koyanagi Y, and Chen ISY: High efficiency transfection of primary human lymphocytes and studies of gene expression. Oncogene 1988;3:123-128.
39. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, and Chen ISY: HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure. Cell 1990; 61:213-222.
40. Zack JA, Haislip AM, Krogstad P, and Chen ISY: Incompletely reverse transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the virus life cycle. J Virol 1992;66:1717-1725.
41. Lawn RM, Efstratindus A, O'Connell C, and Maniatis T: The nucleotide sequence of the human β-globin gene. Cell 1980; 21:647-651.
42. Hall BL, and Finn OJ: PCR-based analysis of usage within the T-cell receptor Vβ multigene family: Considerations affecting the validity of the approach. Biotechniques 1992;13:248-257.
43. Genevee C, Diu A, Nierat J, Gaignard A, Dietrich P-Y, Ferradini L, Roman-Roman S, Triebel F, and Hercend T: An experimentally validated panel of subfamily-specific oligonucleotide primers (Vα1-w 29/Vβ1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol 1992;22:1261-1269.
44. Chen PF and Platsoucas CD: Development of the non-palindromic adaptor polymerase chain reaction (NPA-PCR) for the amplification of alpha- and beta-chain T-cell receptor cDNAs. Scand J Immunol 1992;35:539-549.
45. Wucherpfennig KW, Ota K, Endo N, Seidman JG, Rosenzweig A, Weiner HL, and Hafler DA: Shared human T-cell receptor Vβ usage to immunodominant regions of myelin basic protein. Science 1990;248:1016-1019.
46. Ehrlich GD, Greenberg S, and Abbott M: A guide to methods and applications. In PCR Protocols (Innis MA, Gelfand DH, Sninsky JJ, and White TJ, eds.). Academic Press, San Diego, California, 1990, pp. 325-332.
47. Jamieson BD, Pang S, Aldrovandi GM, Zha J, and Zack JA: In vivo pathogenic properties of two clonal human immunodeficiency virus type 1 isolates. J Virol 1995;69:6259-6264.
48. Tomonari K, Fairchild S, and Rosenwasser OA: Influence of viral superantigens on Vβ- and Vα-specific positive and negative selection. Immunol Rev 1993;131:131-168.
49. Aldrovandi GM and Zack JA: Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice. J Virol 1996;70:1505-1511.
50. Marrack P and Kappler J: The staphylococcal enterotoxins and their relatives. Science 1990;248:705-711.
51. Pantaleo G, Demarest JF, Soudeyns H, Graziosi C, Denis F, Adelsberger JW, Borrow P, Saag MS, Shaw GM, Sekaly RP, and Fauci AS: Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV. Nature (London) 1994;370:463-467.
52. Kollmann TR, Kim A, Pettoello-Mantovani M, Hachamovitch M, Rubinstein A, Goldstein MM, and Goldstein H: Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice. J Immunol 1995;154:907-921.
53. Janeway C: M1s: Makes a little sense. Nature (London) 1991; 349:459-461.
54. Groux H, Torpier G, Monte D, Mouton Y, Capron A, and Ameisen JC: Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992;175:331-340.
55. Laurent-Crawford AG, Krust B, Muller S, Riviére Y, Rey-Cuillé MA, Béchet JM, Montagnier L, and Hovanessian A: The cytopathic effect of HIV is associated with apoptosis. Virology 1991; 185:829-839.
56. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM, and Miedema F: Programmed death of T cells in HIV-1 infection. Science 1992;257:217-219.
57. Terai C, Kornbluth RS, Pauza CD, Richman DD, and Carson DA: Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J Clin Invest 1991;87:1710-1715.
58. Ameisen JC and Capron A: Cell dysfunction and depletion in AIDS: The programmed cell death hypothesis. Immunol Today 1991;12:102-105.
59. Su L, Kaneshima H, Bonyhadi M, Salimi S, Kraft D, Rabin L, and McCune JM: HIV-1-induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo. Immunity 1995;2:25-36.
60. Uittenbogaart CH, Anisman DJ, Jamieson BD, Kitchen S, Schmid I, Zack JA, and Hays EF: Differential tropism of HIV-1 isolates for distinct thymocyte subsets in vitro. AIDS 1996 (in press).